Press "Enter" to skip to content

AstraZeneca first-quarter sales beat estimates on cancer drugs

The company, fresh off an oncology deal with Japan’s Daiichi Sankyo Co Ltd, in February reported annual sales growth for the first time since 2009, turning the business around after a series of patent losses.

Original source:

Also Read:   Stay-at-home orders in major states mark next phase of U.S. coronavirus crisis